•     Testimonials      •     Verdicts      •     Bios      •

Contact Us

Tysabri
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

CORRECTION: MULTIPLE SCLEROSIS DRUG (TYSABRI) MAY HAVE BEEN RESPONSIBLE FOR FOURTH CASE OF RARE BRAIN DISEASE

Jun 4, 2005 | www.Newsinferno.com Yesterday, we reported that the FDA had been informed by Biogen Idec Inc. that a fourth person may have died from a rare and often fatal brain disease known as progressive multifocal leukoencephalopathy (PML) after short-term treatment with its embattled multiple sclerosis drug Tysabri. Actually, that person remains alive and is currently being treated for the disease.